Leidos CFO awarded 73.55 deferred stock shares

Leidos Holdings Chief Financial Officer Christopher R. Cage acquired 73.55 shares of common stock as a grant under the Key Executive Stock Deferral Plan, characterized as dividend equivalent rights.

Rhea-AI Filing Summary

Leidos Holdings Chief Financial Officer Christopher R. Cage acquired 73.55 shares of common stock as a grant under the Key Executive Stock Deferral Plan, characterized as dividend equivalent rights. Following this award, he indirectly holds 31,727.2538 shares through the plan and directly holds 64,829 shares.

Insider Trade Summary

Grant/Award: 73.55 shares

Grant/Award 2 txns

Insider Cage Christopher R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	73.55	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 31,727.2538 shares (Indirect, By Key Executive Stock Deferral Plan); Common Stock — 64,829 shares (Direct)

Footnotes (1)

1. F1. Dividend equivalent rights.

Key Figures

Stock grant: 73.55 shares Indirect holdings after transaction: 31,727.2538 shares Direct holdings after transaction: 64,829 shares

3 metrics

Stock grant 73.55 shares Common stock grant as dividend equivalent rights on 2026-03-31

Indirect holdings after transaction 31,727.2538 shares Indirectly owned via Key Executive Stock Deferral Plan after grant

Direct holdings after transaction 64,829 shares Directly owned common stock position reported as of transaction date

Key Terms

Dividend equivalent rights, Key Executive Stock Deferral Plan, indirect ownership

3 terms

Dividend equivalent rights financial

"Dividend equivalent rights."

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Key Executive Stock Deferral Plan financial

"nature_of_ownership: By Key Executive Stock Deferral Plan"

indirect ownership financial

"ownership_type: indirect; nature_of_ownership: By Key Executive Stock Deferral Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Leidos (LDOS) CFO Christopher Cage report?

Christopher R. Cage reported acquiring 73.55 shares of Leidos common stock as a grant under the Key Executive Stock Deferral Plan. The award is described as dividend equivalent rights, meaning it reflects share-based credits tied to dividends rather than an open-market purchase.

Is the Leidos (LDOS) CFO’s recent Form 4 transaction an open-market trade?

No, the transaction is a grant, not an open-market trade. The 73.55 shares were credited under the Key Executive Stock Deferral Plan as dividend equivalent rights, so there was no market purchase or sale involved and no price was paid per share.

How many Leidos (LDOS) shares does the CFO hold after this transaction?

After the grant, Christopher R. Cage indirectly holds 31,727.2538 Leidos common shares through the Key Executive Stock Deferral Plan and directly holds 64,829 shares. These figures show both his deferred-plan holdings and his direct ownership positions reported in the Form 4.

What does “Key Executive Stock Deferral Plan” mean for Leidos (LDOS) insiders?

The Key Executive Stock Deferral Plan is a program through which certain Leidos executives hold shares indirectly. In this case, 31,727.2538 shares are reported as indirectly owned by the CFO through the plan, reflecting deferred or credited stock-based compensation rather than direct share certificates.

What are “dividend equivalent rights” in the Leidos (LDOS) CFO’s Form 4?

Dividend equivalent rights represent share-based credits linked to dividends on underlying stock rather than cash payments. For the Leidos CFO, the 73.55-share grant is labeled as dividend equivalent rights, increasing his deferred stock balance in the Key Executive Stock Deferral Plan instead of receiving cash.

Does the Leidos (LDOS) CFO’s transaction signal buying or selling pressure?

The transaction reflects an acquisition as a compensation-related grant, not a discretionary market trade. Since the 73.55 shares are dividend equivalent rights credited under a deferral plan at no cost, it does not indicate active buying or selling pressure in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:49 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cage Christopher R

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		73.55(1)	A	$0	31,727.2538	I	By Key Executive Stock Deferral Plan
Common Stock								64,829	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Dividend equivalent rights.

Remarks:

	/s/ Ramune M. Kligys by PoA of Christopher R. Cage	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)